We are currently enrolling for studies in a number of areas, even if the studies are not published publicly below. If you cannot find what you are looking for today, you may contact email@example.com or call (425) 869-6828 to speak with a member of our research team.
Eastside Research Associates - Redmond, WA
8301 161st Ave NE, Suite 204
Redmond, WA 98052
Cold, Flu & COVID-19
Pediatric Strep Throat Swab
evaluating the effectiveness of a gargle specimen for rapid Strep Throat diagnosis in pediatric participants.
This is a study collecting gargle swabs in pediatric patients for rapid strep throat testing.Study participants must be symptomatic of strep and between the ages of 5-15.
Flu & COVID-19 Diagnostic Device
We are now enrolling for a clinical trial evaluating the effectiveness of a diagnostic device for flu and COVID-19.
We have partnered with sponsors who are researching the effectiveness of at home diagnostic devices for flu and COVID-19. Participants will undergo test as well as control nasal swabs to compare the results of each device.
Adults and children who are suspected to have an acute viral infection within the last 7 days may qualify.
Rebound COVID Treatment
We are now enrolling for a clinical trial evaluating the effectiveness of an investigational medication on rebound COVID-19 outcomes.
We have partnered with sponsors who are researching the effectiveness of an investigational oral treatment on the outcomes of high risk individuals who are experiencing rebound COVID-19 symptoms.
High risk adults and children who have a current diagnosis of COVID-19 may qualify.
Glucose Monitoring Study
We are now enrolling for a clinical trial evaluating the effectiveness of a glucose monitoring device for diabetes.
This study is evaluating the effectiveness of a wearable glucose monitoring device for Type 1 and Type 2 diabetics.
Adults and children ages 4 and older with either Type 1 or Type 2 diabetes may qualify.
Cancer Detection Study
We are now enrolling for a clinical trial which is working to improve existing cancer detection lab diagnostic technology.
This is a study collecting a single blood sample from individuals with and without cancer to evaluate current diagnostic technology for cancer. These samples may also be used in the development of future tests.
Adults with benign conditions and/or cancer may qualify.
Cardiovascular Risk Outcomes in Overweight Adults
We are now enrolling for a clinical trial evaluating the effectiveness of an investigational medication on cardiovascular outcomes in high risk overweight adults.
This study is evaluating an investigational medication vs placebo on the long term morbidity and mortality of adults who are overweight and have other cardiovascular risk factors.
High risk adults over 40 years of age with a BMI of 27 or more may qualify.